• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma.新型冠状病毒肺炎、高凝状态与恢复期血浆治疗的谨慎态度
Am J Respir Crit Care Med. 2021 Jan 15;203(2):257-258. doi: 10.1164/rccm.202008-3139LE.
2
Convalescent plasma for COVID-19 considerations.关于新冠病毒病恢复期血浆的考量
Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.
3
[Is convalescent plasma an alternative treatment for Covid-19 patients?].[康复期血浆是新冠病毒肺炎患者的替代治疗方法吗？]
Salud Publica Mex. 2020 Nov-Dec;62(6):870-871. doi: 10.21149/11744.
4
Covid-19 convalescent plasma and SARS-CoV-2 viral variants.新冠康复者血浆与严重急性呼吸综合征冠状病毒2病毒变体
Transfus Clin Biol. 2021 Aug;28(3):306. doi: 10.1016/j.tracli.2021.05.008. Epub 2021 May 29.
5
Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.用于治疗新冠病毒肺炎的康复期血浆——解读其中的不一致之处
N Engl J Med. 2022 May 5;386(18):1753-1754. doi: 10.1056/NEJMe2204332.
6
Rethinking the role of COVID-19 convalescent plasma in the critically ill.重新思考新冠康复者血浆在危重症患者中的作用。
Transfus Apher Sci. 2023 Feb;62(1):103521. doi: 10.1016/j.transci.2022.103521. Epub 2022 Aug 4.
7
Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19.康复期血浆和SARS-CoV-2高免疫静脉注射人免疫球蛋白对循环中的SARS-CoV-2德尔塔和奥密克戎变体的中和作用用于治疗新冠肺炎。
Ann Rheum Dis. 2022 Jul;81(7):1044-1045. doi: 10.1136/annrheumdis-2022-222115. Epub 2022 Feb 10.
8
Convalescent plasma for COVID-19 - encouraging signals of efficacy.用于治疗新冠肺炎的康复期血浆——疗效的鼓舞人心信号。
Br J Haematol. 2021 Feb;192(4):681-682. doi: 10.1111/bjh.17270. Epub 2021 Feb 1.
9
Use of Convalescent Plasma in the Management of COVID-19.康复期血浆在新型冠状病毒肺炎治疗中的应用
Mo Med. 2021 Mar-Apr;118(2):118.
10
[COVID-19: blood sufficiency versus convalescent plasma?].[新冠病毒肺炎：血液充足疗法与康复期血浆疗法？]
Rev Med Chil. 2020 Jun;148(6):721-723. doi: 10.4067/S0034-98872020000600721.

引用本文的文献

1
Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism.2019冠状病毒病门诊患者与住院患者恢复期血浆治疗：疗效及血栓栓塞风险
Res Pract Thromb Haemost. 2023 Feb;7(2):100068. doi: 10.1016/j.rpth.2023.100068. Epub 2023 Feb 6.
2
The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis.康复期血浆治疗2019年新型冠状病毒病的有效性：一项系统评价和荟萃分析。
Front Med (Lausanne). 2021 Sep 27;8:641429. doi: 10.3389/fmed.2021.641429. eCollection 2021.
3
Adverse Cardiovascular Effects of Anti-COVID-19 Drugs.抗新冠病毒药物的心血管不良影响。
Front Pharmacol. 2021 Aug 25;12:699949. doi: 10.3389/fphar.2021.699949. eCollection 2021.
4
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.一项关于恢复期血浆治疗成人重症 COVID-19 的随机、双盲、对照临床试验。
J Clin Invest. 2021 Jul 1;131(13). doi: 10.1172/JCI150646.
5
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.

本文引用的文献

1
Efficacy of convalescent plasma for the treatment of severe influenza.恢复期血浆治疗重症流感的疗效。
Crit Care. 2020 Jul 29;24(1):469. doi: 10.1186/s13054-020-03189-7.
2
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations.严重 COVID-19 中的肺血管病：生理学、影像学和血液学观察。
Am J Respir Crit Care Med. 2020 Sep 1;202(5):690-699. doi: 10.1164/rccm.202004-1412OC.
3
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.新冠康复者血浆或超免疫球蛋白用于新冠患者：快速综述
Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600.
4
COVID-19 pneumonia: different respiratory treatments for different phenotypes?新冠肺炎：针对不同表型采用不同的呼吸治疗方法？
Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.
5
Plasma treated with methylene blue and light: clinical efficacy and safety profile.亚甲蓝联合光处理的血浆：临床疗效和安全性特征。
Transfus Med Rev. 2013 Oct;27(4):235-40. doi: 10.1016/j.tmrv.2013.08.001. Epub 2013 Sep 24.

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma.

作者信息

Sanfilippo Filippo, La Rosa Valeria, Oliveri Francesco, Astuto Marinella

机构信息

Azienda Ospedaliero Universitaria "Policlinico-Vittorio Emanuele" Catania, Italy and.

University of Catania Catania, Italy.

出版信息

Am J Respir Crit Care Med. 2021 Jan 15;203(2):257-258. doi: 10.1164/rccm.202008-3139LE.

DOI:10.1164/rccm.202008-3139LE
PMID:33085908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7874424/
Abstract
摘要